Specific self-monitoring of metal-associated amyloid-β peptide disaggregation by a fluorescent chelator.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Chemical Communications

• Publication date

  2016-01-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c5cc08898dPMID 26688576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of Beta-Amyloid Fibrillation by Luminescent Iridium(III) Complex Probes

  2015cited by this paper
• Imaging of β-amyloid plaques by near infrared fluorescent tracers: a new frontier for chemical neuroscience.

  2015cited by this paper
• Site-selective recognition of peptide phosphorylation by a terbium(III) complex in aqueous solution.

  2015cited by this paper
• A bifunctional curcumin analogue for two-photon imaging and inhibiting crosslinking of amyloid beta in Alzheimer's disease.

  2014cited by this paper
• The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.

  2014cited by this paper
• Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

  2013cited by this paper
• The benzazole scaffold: a SWAT to combat Alzheimer's disease.

  2013cited by this paper
• Inhibitory action of macrocyclic platiniferous chelators on metal-induced Aβ aggregation

  2012cited by this paper
• The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases

  2012cited by this paper
• Insight into Amyloid Structure Using Chemical Probes

  2011cited by this paper
• Natural tri- to hexapeptides self-assemble in water to amyloid β-type fiber aggregates by unexpected α-helical intermediate structures

  2011cited by this paper
• Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

  2011cited by this paper
• Molecular mechanism of Thioflavin-T binding to amyloid fibrils.

  2010cited by this paper
• Biomarkers in Alzheimer's disease drug development

  2010cited by this paper
• Chelation therapy for neurodegenerative diseases

  2009cited by this paper
• Effects of cyclen and cyclam on zinc(II)- and copper(II)-induced amyloid beta-peptide aggregation and neurotoxicity.

  2009cited by this paper
• Coumarin-derived Cu(2+)-selective fluorescence sensor: synthesis, mechanisms, and applications in living cells.

  2009cited by this paper
• Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.

  2009cited by this paper
• Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

  2009cited by this paper
• Metals in neurobiology: probing their chemistry and biology with molecular imaging.

  2008cited by this paper
• Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on β-Amyloid Peptide Fibrils*

  2005cited by this paper
• ADMET in silico modelling: towards prediction paradise?

  2003cited by this paper
• The rhodafluor family. An initial study of potential ratiometric fluorescent sensors for Zn2+.

  2002cited by this paper
• Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain.

  2001cited by this paper

• Discovery of NIRF theranostic probes targeting amyloid-β and cholinesterases in Alzheimer’s disease models

  2026cites this paper
• Synthesis and bio-activities of bifunctional tetrahydrosalen Cu (II) chelators with potential efficacy in Alzheimer's disease therapy.

  2024cites this paper
• Role of copper chelating agents: between old applications and new perspectives in neuroscience

  2024influential citation
• Role of Amyloidogenic and Non‐Amyloidogenic Protein Spaces in Neurodegenerative Diseases and their Mitigation Using Theranostic Agents

  2024cites this paper
• Small-molecule theranostics in Alzheimer's disease.

  2023cites this paper
• Recent progress of small-molecule-based theranostic agents in Alzheimer's disease.

  2023cites this paper
• A Nanoenzyme Constructed from Manganese and Strandberg-Type Phosphomolybdate with Versatility in Antioxidant and Modulating Conformation of Aβ Protein Misfolding Aggregates In Vitro

  2023cites this paper
• A Cyclen-Functionalized Cobalt-Substituted Sandwich-Type Tungstoarsenate with Versatility in Removal of Methylene Blue and Anti-ROS-Sensitive Tumor Cells

  2022cites this paper
• A ratiometric fluorescent sensor based on metalloenzyme mimics for detecting organophosphorus pesticides

  2022cites this paper
• Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer's Disease.

  2022cites this paper
• Functional bioprobe for responsive imaging and inhibition of amyloid-β oligomer based on curcuminoid scaffold

  2021cites this paper
• Enzyme mimics based membrane reactor for di(2-ethylhexyl) phthalate degradation.

  2021cites this paper
• Advances in fluorescent probes for detection and imaging of amyloid-β peptides in Alzheimer's disease.

  2021cites this paper
• Diagnostic and theranostic intranasal nanointerventions for brain diseases

  2021cites this paper
• A label-free fluorescent probe for dynamic in situ visualization of amyloid-β peptides aggregation

  2021cites this paper
• Multifunctional nano-enabled delivery systems in Alzheimer's disease management.

  2020cites this paper
• Determination of the Aggregate Binding Site of Amyloid Protofibrils Using Electron Capture Dissociation Tandem Mass Spectrometry.

  2020cites this paper
• A β-sheet-targeted theranostic agent for diagnosing and preventing aggregation of pathogenic peptides in Alzheimer’s disease

  2020cites this paper
• Determination of the Aggregate Binding Site of Amyloid Protofi-brils Using Electron Capture Dissociation Tandem MS

  2020cites this paper
• Small molecule-mediated co-assembly of amyloid-β oligomers reduces neurotoxicity through promoting non-fibrillar aggregation†

  2020cites this paper
• Modulating Conformation of Aβ-Peptide: An Effective Way to Prevent Protein-Misfolding Disease.

  2018cites this paper
• Amyloid β-targeted metal complexes for potential applications in Alzheimer's disease.

  2018cites this paper
• Metal-involved theranostics: An emerging strategy for fighting Alzheimer’s disease

  2018cites this paper
• Probing the structure-activity relationship of a novel artificial cellobiose hydrolase.

  2017cites this paper
• Carbon Nanodot-Sensitized Modulation of Alzheimer's β-Amyloid Self-Assembly, Disassembly, and Toxicity.

  2017cites this paper
• 1.04 – From Imaging Agents to Theranostic Drugs in Alzheimer’s Disease

  2017cites this paper
• A copper–amyloid-β targeted fluorescent chelator as a potential theranostic agent for Alzheimer's disease

  2016cites this paper
• A theranostic agent for in vivo near-infrared imaging of β-amyloid species and inhibition of β-amyloid aggregation.

  2016cites this paper
• From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer's Disease?

  2016cites this paper
• Recent Updates on the Role and Challenges of Nanotherapeutics in Diagnosis and Management of Epilepsy, Neurodegenerative Diseases

  year unknowncites this paper